The developmental regulation of two recently described cytoskeletal proteins (endo A and endo B), which are found in parietal endodermal cell lines but not in a variety of mesodermal cell lines or keratinocytes, will be studied in preimplantation mouse embryos, parietal endodermal cell lines, and cell lines derived from murine teratocarcinomas. The cytoskeletal proteins of blastocyst stage mouse embryos will be compared to the endo A and B cytoskeletal proteins by immunofluoresence, immunoprecipitation, and two-dimensional gel electrophoresis in order to determine if these proteins are associated with trophectoderm, the first differentiated cell type to appear during development. Amino acid sequences of the N-terminal regions of cyanogen bromide fragments generated from purified endo B protein will be determined. Cell-free translation of the poly(A)+ RNAs of embryonal carcinoma (ec) cells, parietal endodermal cells, and of embryonal carcinoma cells induced to differentiate by exposure to retinoic acid will be used to define differences in the mRNA populations of ec and parietal endodermal cells. The time of appearance of translatable endo B mRNA will be compared to the time of appearance of the proteins in ec cells exposed to retinoic acid. The endo B mRNA will be purified from polyribosome preparations by immunochemical means, and the endo B cDNA will be cloned in the pBR322 recombinant plasmid and subcloned in M13 phage. The DNA sequence of the cloned gene will be determined. The cloned endo B cDNA will be used as a probe to determine the methylation state of certain endo B coding sequences in ec cells, retinoic acid-induced ec cells, parietal endodermal cells, fibroblasts, and myoblasts. The state of endo B sequences within nuclei of the same cell types will be compared by brief digestion of isolated nucleic with DNase I followed by restriction enzyme digestion of the DNA and Southern blot hybridization analysis. (M)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA033946-04
Application #
3171691
Study Section
Molecular Biology Study Section (MBY)
Project Start
1982-06-01
Project End
1986-09-29
Budget Start
1985-09-30
Budget End
1986-09-29
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Kulesh, D A; Oshima, R G (1989) Complete structure of the gene for human keratin 18. Genomics 4:339-47
Kulesh, D A; Cecena, G; Darmon, Y M et al. (1989) Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol 9:1553-65
Oshima, R G (1988) Rapid identification of M13 phage deletions for sequence analysis. Biotechniques 6:510-1
Oshima, R G; Trevor, K; Shevinsky, L H et al. (1988) Identification of the gene coding for the Endo B murine cytokeratin and its methylated, stable inactive state in mouse nonepithelial cells. Genes Dev 2:505-16
Kulesh, D A; Oshima, R G (1988) Cloning of the human keratin 18 gene and its expression in nonepithelial mouse cells. Mol Cell Biol 8:1540-50
Trevor, K; Linney, E; Oshima, R G (1987) Suppression of endo B cytokeratin by its antisense RNA inhibits the normal coexpression of endo A cytokeratin. Proc Natl Acad Sci U S A 84:1040-4
Izhar, M; Siebert, P D; Oshima, R G et al. (1986) Trophoblastic differentiation of human teratocarcinoma cell line HT-H1. Dev Biol 116:510-8
Singer, P A; Trevor, K; Oshima, R G (1986) Molecular cloning and characterization of the Endo B cytokeratin expressed in preimplantation mouse embryos. J Biol Chem 261:538-47
Howe, W E; Klier, F G; Oshima, R G (1986) Murine endodermal cytokeratins Endo A and Endo B are localized in the same intermediate filament. J Histochem Cytochem 34:785-93
Oshima, R G; Millan, J L; Cecena, G (1986) Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation. Differentiation 33:61-8

Showing the most recent 10 out of 11 publications